Tcr2 Therapeutics Inc (TCRR) stock is up 132.73% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives TCRR stock a score of 73 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 93. TCRR's rank also includes a short-term technical score of 67. The fundamental score for TCRR is 60. In addition to the average rating from Wall Street analysts, TCRR stock has a mean target price of 42.714. This means analysts expect the stock to add 32.61% over the next 12 months.
What's Happening with TCRR Stock Today
Tcr2 Therapeutics Inc (TCRR) stock has fallen -1.8% while the S&P 500 is up 0.86% as of 1:31 PM on Tuesday, Jan 19. TCRR has fallen -$0.59 from the previous closing price of $32.80 on volume of 204,027 shares. Over the past year the S&P 500 has risen 14.45% while TCRR is up 132.73%. TCRR lost -$2.41 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Tcr2 Therapeutics Inc (TCRR) Stock.
